Clinical trial
Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
NCT00181168 · Johns Hopkins University, Other · Completed
Key facts
| NCT number | NCT00181168 |
|---|---|
| Title | Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer |
| Official title | Utility of Recombinant Human Thyrotropin (rTSH) PET-CT Fusion Scanning to Identify Residual Well-differentiated Epithelial Thyroid Cancer |
| Lead sponsor | Johns Hopkins University, Other |
| Collaborators | Gustave Roussy, Cancer Campus, Grand Paris M.D. Anderson Cancer Center Genzyme, a Sanofi Company Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Thyroid Cancer |
| Intervention type | Drug |
| Interventions | Euthyroid Group |
| Enrollment | 63 |
| Start date | Mar 1, 2001 |
| Primary completion | Sep 1, 2003 |
| Completion | Sep 1, 2003 |
| First posted | Sep 16, 2005 |
| Last update posted | Nov 2, 2018 |
| Countries | France, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: